The PTH/PTHrP receptor works through at least two distinct signaling pathways by activation both Gs and the Gq family. Previous studies have provided suggestive but inconclusive evidence concerning the linkage of specific second message pathways and particular distal actions of PTH and PTHrP in kidney and bone. The goal of this proposal is to establish the physiologic roles of specific second messenger pathways in PTH and PTHrP action in vivo. Lines of mice have been established in which the normal PTH/PTHrP receptor gene is replaced with a mutant receptor gene. In this mutant receptor, the alteration of four adjacent residues leads to dramatic blunting of activation of Gq without affecting the activation of Gs. Analysis of the effects of inactivating the Gq pathway on tissue responsiveness in intact animals will establish the physiologic roles of the Gq pathway in the actions of PTH and PTHrP. The results may help in the design of ways to control hypercalcemia and to use the anabolic actions of PTH to treat osteoporosis.
Specific Aim I of the proposal will be to determine the role of PLC signaling by the PTH/PTHrP receptor in the growth plate, following up the discovery that these mice have abnormal growth plates.
Specific Aim II will evaluate the effects of the mutation on the bone responses to PTH. Particular focus will be placed on the regulation of the anabolic effect of PTH and the stimulation by PTH of bone resorption.
Specific Aim III will study the effects of the mutation on the renal responses to PTH, since calcium and phosphorus homeostasis are disrupted when these mice are challenged with a low calcium diet. Particular focus will be placed on the regulation of sodium-phosphate co-transport and of 25-hydroxyvitamin D 1alpha-hydroxylation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK011794-38
Application #
7160506
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2005-12-01
Project End
2008-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
38
Fiscal Year
2006
Total Cost
$307,778
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Christov, Marta; Clark, Abbe R; Corbin, Braden et al. (2018) Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight 3:
Dedic, Christopher; Hung, Tin Shing; Shipley, Alan M et al. (2018) Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes. Bone 116:135-143
Mizuhashi, Koji; Ono, Wanida; Matsushita, Yuki et al. (2018) Resting zone of the growth plate houses a unique class of skeletal stem cells. Nature 563:254-258
Hanna, Patrick; Grybek, Virginie; Perez de Nanclares, Guiomar et al. (2018) Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity. J Bone Miner Res 33:1480-1488
Wein, Marc N; Foretz, Marc; Fisher, David E et al. (2018) Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends Endocrinol Metab 29:723-735
Bastepe, Murat (2018) GNAS mutations and heterotopic ossification. Bone 109:80-85
Roszko, Kelly L; Bi, Ruiye; Gorvin, Caroline M et al. (2017) Knockin mouse with mutant G?11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors. JCI Insight 2:e91079
Grigelioniene, Giedre; Nevalainen, Pasi I; Reyes, Monica et al. (2017) A Large Inversion Involving GNAS Exon A/B and All Exons Encoding Gs? Is Associated With Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B). J Bone Miner Res 32:776-783
Balani, Deepak H; Ono, Noriaki; Kronenberg, Henry M (2017) Parathyroid hormone regulates fates of murine osteoblast precursors in vivo. J Clin Invest 127:3327-3338
Cheloha, Ross W; Chen, Bingming; Kumar, Niyanta N et al. (2017) Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad ? Residue Distribution. J Med Chem 60:8816-8833

Showing the most recent 10 out of 215 publications